Legal & General Group Plc - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$10,0000.0%4,5520.0%0.00%
Q4 2020$10,000
-16.7%
4,5520.0%0.00%
Q3 2020$12,000
-40.0%
4,552
-30.4%
0.00%
Q2 2020$20,000
+53.8%
6,540
-4.9%
0.00%
Q1 2020$13,000
-51.9%
6,878
-25.8%
0.00%
Q4 2019$27,000
-3.6%
9,266
+20.9%
0.00%
Q3 2019$28,000
+27.3%
7,666
+43.0%
0.00%
Q2 2019$22,0005,3610.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$401,0000.10%
Geneos Wealth Management Inc. 511,606$2,261,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$26,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 18,967$41,0000.01%
Vivaldi Capital Management LP 10,668$45,0000.01%
OSAIC HOLDINGS, INC. 1,221,984$2,651,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$34,0000.00%
WEDBUSH SECURITIES INC 17,998$39,0000.00%
D.A. DAVIDSON & CO. 65,310$142,0000.00%
Virtu Financial LLC 14,683$32,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders